Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to -$1.3 billion.

  • Standard Biotools' Retained Earnings fell 1113.7% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 1113.7%. This contributed to the annual value of -$1.2 billion for FY2024, which is 1847.6% down from last year.
  • As of Q3 2025, Standard Biotools' Retained Earnings stood at -$1.3 billion, which was down 1113.7% from -$1.2 billion recorded in Q2 2025.
  • Standard Biotools' Retained Earnings' 5-year high stood at -$695.6 million during Q1 2021, with a 5-year trough of -$1.3 billion in Q3 2025.
  • Its 5-year average for Retained Earnings is -$976.4 million, with a median of -$960.0 million in 2023.
  • Per our database at Business Quant, Standard Biotools' Retained Earnings plummeted by 2582.86% in 2022 and then crashed by 806.14% in 2023.
  • Quarter analysis of 5 years shows Standard Biotools' Retained Earnings stood at -$736.0 million in 2021, then decreased by 25.83% to -$926.1 million in 2022, then decreased by 8.06% to -$1.0 billion in 2023, then decreased by 18.48% to -$1.2 billion in 2024, then fell by 7.94% to -$1.3 billion in 2025.
  • Its last three reported values are -$1.3 billion in Q3 2025, -$1.2 billion for Q2 2025, and -$1.2 billion during Q1 2025.